105
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Constitutive NF-κB/Rel Activation in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

, , , &
Pages 1181-1184 | Received 28 Nov 2003, Published online: 03 Aug 2009

Reference

  • Kurzrock, R., Gutterman, J.U. and Talpaz, M. (1988) "The molecular genetics of Philadelphia chromosome-positive leuke-mias", New England Journal of Medicine, 319, 990–998.
  • Gleissner, B., Gi5kbuget, N., Bartram, C.R., Janssen, B., Rieder, H., Janssen, J.W., et al. (2002) "Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis", Blood, 99, 1536–1543.
  • Sawyers, C.L. (1997) "Signal transduction pathways involved in BCR-ABL transformation", Baillieres Clinical Haematology, 10, 223–231.
  • Hamdane, M., David-Cordonnier, M.H. and D'Halluin, J.C. (1997) "Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB)", Oncogene, 15, 2267–2275.
  • Reuther, J.Y., Reuther, G.W., Cortez, D., Pendergast, A.M. and Baldwin, A.S. Jr. (1998) "A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation", Genes and Development, 12, 968–981.
  • Kirchner, D., Duyster, J., Ottmann, 0., Schmid, R.M., Bergmann, L. and Munzert, G. (2003) "Mechanisms of Bcr-Abl-mediated NF-KB/Rel activation", Experimental Hematology, 31, 504–511.
  • Karin, M. and Ben-Neriah, Y. (2000) "Phosphorylation meets ubiquitination: the control of NF-KB activity", Annual Reviews in Immunology, 18, 621–663.
  • Wu, M., Lee, H., Bellas, R.E., Schauer, S.L., Arsura, M., Katz, D., et al. (1996) "Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells", Embo Journal, 15, 4682–4690.
  • Munzert, G., Kirchner, D., Stobbe, H., Bergmann, L., Schmid, R.M., Döhner, H. et al. (2002) "Tumor Necrosis Factor (TNF) Receptor-Associated Factor 1 Gene (TRAF1) Overexpression in B-Cell Chronic Lymphocytic Leukemia (B-CLL)", Blood, 100, 3749–3756.
  • Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dörken, B. and Scheidereit, C. (2001) "Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells", Blood, 97, 2798–2807.
  • Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) "Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei", Nucleic Acid Research, 11, 1475–1489.
  • Baldwin, A.S. Jr. and Sharp, P.A. (1987) "Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene", Molecular Cellular Biology, 7, 305–313.
  • Sen, R. and Baltimore, D. (1986) "Multiple nuclear factors interact with the immunoglobulin enhancer sequences", Cell, 46, 705–716.
  • Miyamoto, S., Schmitt, M.J. and Verma, IM. (1994) "Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation", Proceedings of the National Academy of Sciences US A, 91, 5056–5060.
  • Liou, H.C., Sha, W.C., Scott, M.L. and Baltimore, D. (1994) "Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation", Molecular Cellular Biology, 14, 5349–5359.
  • Bentires-Alj, M., Hellin, A.C., Ameyar, M., Chouaib, S., Merville, M.P. and Bours, V. (1999) "Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs", Cancer Research, 59, 811–815.
  • Wang, C.Y., Cusack, J.C. Jr., Liu, R. and Baldwin, AS. Jr. (1999) "Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB", Nature Medicine, 5, 412–417.
  • Cortez, D., Kadlec, L. and Pendergast, A.M. (1995) "Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis", Molecular Cellular Biology, 15, 5531–5541.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.